ZA200906467B - Imidazolidinone derivatives - Google Patents
Imidazolidinone derivativesInfo
- Publication number
- ZA200906467B ZA200906467B ZA200906467A ZA200906467A ZA200906467B ZA 200906467 B ZA200906467 B ZA 200906467B ZA 200906467 A ZA200906467 A ZA 200906467A ZA 200906467 A ZA200906467 A ZA 200906467A ZA 200906467 B ZA200906467 B ZA 200906467B
- Authority
- ZA
- South Africa
- Prior art keywords
- imidazolidinone derivatives
- imidazolidinone
- derivatives
- Prior art date
Links
- 150000008624 imidazolidinones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07105376 | 2007-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200906467B true ZA200906467B (en) | 2010-05-26 |
Family
ID=39661434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200906467A ZA200906467B (en) | 2007-03-30 | 2009-09-16 | Imidazolidinone derivatives |
Country Status (22)
Country | Link |
---|---|
US (1) | US7625902B2 (xx) |
EP (1) | EP2142533B1 (xx) |
JP (1) | JP5165748B2 (xx) |
KR (1) | KR101171433B1 (xx) |
CN (1) | CN101641348B (xx) |
AR (1) | AR065863A1 (xx) |
AT (1) | ATE533761T1 (xx) |
AU (1) | AU2008234017B2 (xx) |
BR (1) | BRPI0809680A2 (xx) |
CA (1) | CA2681809C (xx) |
CL (1) | CL2008000875A1 (xx) |
DK (1) | DK2142533T3 (xx) |
ES (1) | ES2375586T3 (xx) |
IL (1) | IL200868A0 (xx) |
MX (1) | MX2009010567A (xx) |
PE (1) | PE20090549A1 (xx) |
PL (1) | PL2142533T3 (xx) |
PT (1) | PT2142533E (xx) |
RU (1) | RU2437882C2 (xx) |
TW (1) | TWI348908B (xx) |
WO (1) | WO2008119657A1 (xx) |
ZA (1) | ZA200906467B (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103772299A (zh) | 2007-08-13 | 2014-05-07 | 霍夫曼-拉罗奇有限公司 | 新型哌嗪酰胺衍生物 |
EP2242745A1 (de) * | 2008-02-07 | 2010-10-27 | Sanofi-Aventis | Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
WO2012033353A2 (ko) | 2010-09-07 | 2012-03-15 | 서울대학교 산학협력단 | 세스터터핀 화합물 및 이들 물질의 용도 |
PT2968316T (pt) | 2013-03-13 | 2019-10-29 | Forma Therapeutics Inc | Derivados de 2-hidroxi-1-{4-[(4-fenilfenil)carbonil]piperazin-1-il}etano-1-ona e compostos relacionados como inibidores da sintase de ácidos gordos (fasn) para o tratamento do cancro |
WO2017083216A1 (en) * | 2015-11-12 | 2017-05-18 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
EA039859B1 (ru) | 2016-02-03 | 2022-03-21 | Эмджен Рисерч (Мюник) Гмбх | Биспецифические конструкты антител, связывающие egfrviii и cd3 |
WO2019023448A1 (en) * | 2017-07-26 | 2019-01-31 | Emory University | INHIBITORS OF NADPH OXIDASE AND THEIR USE |
TWI748194B (zh) | 2018-06-28 | 2021-12-01 | 德商菲尼克斯 Fxr有限責任公司 | 含有雙環核心部分之新穎lxr調節劑 |
TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
CN113382633A (zh) | 2018-10-29 | 2021-09-10 | 福马治疗股份有限公司 | (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式 |
US20230039836A1 (en) * | 2020-01-10 | 2023-02-09 | Uniwersytet Jagiellonski | Aromatic sulphonamides derivatives that inhibits pdi a3, their synthesis and use |
US20230069886A1 (en) * | 2020-01-10 | 2023-03-09 | Uniwersytet Jagiellonski | Aromatic sulphonamides derivatives that inhibits pdi a3, their synthesis and use |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001511799A (ja) * | 1997-02-13 | 2001-08-14 | ゼネカ・リミテッド | オキシド−スクアレンシクラーゼ阻害剤として有用なヘテロ環式化合物 |
US6316503B1 (en) * | 1999-03-15 | 2001-11-13 | Tularik Inc. | LXR modulators |
AU2000235960A1 (en) * | 2000-02-14 | 2001-08-27 | Tularik, Inc. | Lxr modulators |
EP1318976B1 (en) * | 2000-09-18 | 2004-11-24 | Glaxo Group Limited | Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
MXPA04011691A (es) * | 2002-05-24 | 2005-09-12 | Pharmacia Corp | Moduladores del receptor x anilino hepaticos. |
US20050192286A1 (en) * | 2003-10-22 | 2005-09-01 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
AU2005267331A1 (en) * | 2004-06-24 | 2006-02-02 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
CN1972897A (zh) | 2004-06-28 | 2007-05-30 | 霍夫曼-拉罗奇有限公司 | 新型六氟异丙醇衍生物 |
DE102005000666B3 (de) * | 2005-01-04 | 2006-10-05 | Sanofi-Aventis Deutschland Gmbh | Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
2008
- 2008-03-18 EP EP08717926A patent/EP2142533B1/en not_active Not-in-force
- 2008-03-18 PL PL08717926T patent/PL2142533T3/pl unknown
- 2008-03-18 WO PCT/EP2008/053192 patent/WO2008119657A1/en active Application Filing
- 2008-03-18 ES ES08717926T patent/ES2375586T3/es active Active
- 2008-03-18 CA CA2681809A patent/CA2681809C/en not_active Expired - Fee Related
- 2008-03-18 CN CN200880009826.7A patent/CN101641348B/zh not_active Expired - Fee Related
- 2008-03-18 DK DK08717926.3T patent/DK2142533T3/da active
- 2008-03-18 RU RU2009139915/04A patent/RU2437882C2/ru not_active IP Right Cessation
- 2008-03-18 MX MX2009010567A patent/MX2009010567A/es active IP Right Grant
- 2008-03-18 BR BRPI0809680-5A2A patent/BRPI0809680A2/pt not_active IP Right Cessation
- 2008-03-18 PT PT08717926T patent/PT2142533E/pt unknown
- 2008-03-18 AU AU2008234017A patent/AU2008234017B2/en not_active Ceased
- 2008-03-18 JP JP2010501464A patent/JP5165748B2/ja not_active Expired - Fee Related
- 2008-03-18 KR KR1020097022619A patent/KR101171433B1/ko not_active IP Right Cessation
- 2008-03-18 AT AT08717926T patent/ATE533761T1/de active
- 2008-03-24 US US12/053,674 patent/US7625902B2/en not_active Expired - Fee Related
- 2008-03-27 CL CL200800875A patent/CL2008000875A1/es unknown
- 2008-03-27 TW TW097111130A patent/TWI348908B/zh not_active IP Right Cessation
- 2008-03-27 AR ARP080101267A patent/AR065863A1/es not_active Application Discontinuation
- 2008-03-27 PE PE2008000551A patent/PE20090549A1/es not_active Application Discontinuation
-
2009
- 2009-09-10 IL IL200868A patent/IL200868A0/en unknown
- 2009-09-16 ZA ZA200906467A patent/ZA200906467B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0809680A2 (pt) | 2014-10-07 |
PT2142533E (pt) | 2012-01-19 |
ATE533761T1 (de) | 2011-12-15 |
TW200848046A (en) | 2008-12-16 |
CA2681809A1 (en) | 2008-10-09 |
CN101641348B (zh) | 2014-09-10 |
ES2375586T3 (es) | 2012-03-02 |
KR101171433B1 (ko) | 2012-08-06 |
AU2008234017A1 (en) | 2008-10-09 |
TWI348908B (en) | 2011-09-21 |
US20080242677A1 (en) | 2008-10-02 |
JP5165748B2 (ja) | 2013-03-21 |
RU2009139915A (ru) | 2011-05-10 |
RU2437882C2 (ru) | 2011-12-27 |
US7625902B2 (en) | 2009-12-01 |
WO2008119657A1 (en) | 2008-10-09 |
CL2008000875A1 (es) | 2008-10-03 |
MX2009010567A (es) | 2009-10-22 |
EP2142533A1 (en) | 2010-01-13 |
AR065863A1 (es) | 2009-07-08 |
AU2008234017B2 (en) | 2011-09-22 |
CN101641348A (zh) | 2010-02-03 |
PE20090549A1 (es) | 2009-05-09 |
JP2010523514A (ja) | 2010-07-15 |
PL2142533T3 (pl) | 2012-04-30 |
CA2681809C (en) | 2012-06-05 |
IL200868A0 (en) | 2010-05-17 |
DK2142533T3 (da) | 2011-12-12 |
KR20090130090A (ko) | 2009-12-17 |
EP2142533B1 (en) | 2011-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1149756A1 (en) | Isoxazolo-pyridine derivatives | |
IL205753A0 (en) | Isoxazolo-pyridazine derivatives | |
EP2120569A4 (en) | SPIROCHROMANONDERIVATE | |
IL202020A0 (en) | Spiroindolinone derivatives | |
TWI348908B (en) | Imidazolidinone derivatives | |
HK1148283A1 (en) | Heterocyclic derivatives | |
ZA201001058B (en) | Quinazolinamide derivatives | |
ZA201000431B (en) | Indazolamide derivatives | |
IL205755A0 (en) | Isoxazolo-pyrazine derivatives | |
ZA201003125B (en) | Imidazole derivatives | |
IL200618A0 (en) | Aza-pyridopyrimidinone derivatives | |
IL205148A0 (en) | Novel imidazole derivatives | |
IL202667A0 (en) | Isoxazole-imidazole derivatives | |
PL2245028T3 (pl) | Pochodne 5-aminocyklilometyloksazolidyn-2-onu | |
ZA201002580B (en) | Heterocyclic derivatives | |
EP2133347A4 (en) | 1-BIARYLAZETIDINONDERIVATE | |
HK1141009A1 (en) | Sulfonyl-quinoline derivatives | |
IL205149A0 (en) | Novel imidazole derivatives | |
IL202159A0 (en) | Piperidine-amide derivatives | |
HK1146276A1 (en) | Thiadiazinone derivatives | |
EP2204368A4 (en) | 4-SULFONYLPIPERIDINE DERIVATIVES | |
ZA201000311B (en) | Sulfonyl-quinoline derivatives | |
AP2009005065A0 (en) | Sulfonyl-quinoline derivatives | |
GB0702266D0 (en) | 7-Azaindoe derivatives | |
ZA201002519B (en) | Novel imidazole derivatives |